Alpha-fetoprotein-specific transfer factors downregulate alpha-fetoprotein expression and specifically induce apoptosis in Bel7402 alpha-fetoprotein-positive hepatocarcinoma cells

Hepatology Research

Volumn 37, Issue 7, 2007, Pages 557-567

  Zhang, Hui ^a   Bai, Zengliang ^a   Chen, Jing ^a   Wang, Ze ^a   Li, Juan ^a  

^a SHANDONG UNIVERSITY   (China)

Author keywords

Alpha fetoprotein; Alpha fetoprotein specific transfer factors; Apoptosis; Bel7402

Indexed keywords

ALPHA FETOPROTEIN; ALPHA FETOPROTEIN SPECIFIC TRANSFER FACTOR; CALCIUM; CASPASE 3; CASPASE 9; CYTOCHROME C; FLUO 3; PROTEIN BAX; PROTEIN BCL 2; RHODAMINE 123; TRANSFER FACTOR; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CALCIUM CELL LEVEL; CANCER CELL CULTURE; CELL CYCLE; CELL VIABILITY; CONTROLLED STUDY; CYTOSOL; DOWN REGULATION; ENZYME ACTIVITY; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; LIVER CELL CARCINOMA; MEMBRANE DAMAGE; MEMBRANE POTENTIAL; MITOCHONDRIAL MEMBRANE; NICK END LABELING; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; PROTEIN SECRETION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STAINING; WESTERN BLOTTING; WHOLE CELL;

EID: 34249903598     PISSN: 13866346     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1872-034X.2007.00078.x     Document Type: Article

References (28)

1. Katsuya S, Koujiro T. New serological markers for hepatocellular carcinoma. Hepatol Res 2005; 33: 195-7.
2. Thomas MB, Zhu AX. Hepatocellular carcinoma: The need for progress. J Clin Oncol 2005; 23: 2892-9.
3. Abelev GI. Alpha-fetoprotein in ontogenesis and its association with malignant tumors. Adv Cancer Res 1971; 14: 295-304.
4. Alava MA, Iturralde M, Lampreave F, Pineiro A. Specific uptake of alpha-fetoprotein and albumin by rat Morris hepatoma cells. Tumour Biol 1999; 20: 52-64.
5. Xing WW, Xu B. Stimulation of tumor-cell growth by alpha-fetoprotein. In J Cancer 1998; 75: 596-9.
6. Yamashita T, Nakane A, Watanabe T, Miyoshi I, Kasai NE. Evidence that alpha-fetoprotein suppress the immunological function in transgenic mice. Biochem Biophys Res Commun 1994; 201: 1154-9.
7. Li MS, Liu XH, Zhou S, Li PF, Li G. Effects of alpha-fetoprotein on escape of Bel7402 cells from attack of lymphocytes. BMC Cancer 2005; 5: 96-103.
8. Fudenberg HH, Pizza G. Transfer factor 1993, new frontiers. Prog Drug Res 1993; 42: 309-400.
9. Kirkpatrick CH. Transfer factors: Identification of conserved sequences in transfer factor molecules. Mol Med 2000; 6: 332-41.
10. Fabre RA, Perez TM, Aguilar LD et al. Transfer factors as immunotherapy and supplement of chemotherapy in experimental pulmonary tuberculosis. Clin Exp Immunol 2004; 136: 215-23.
11. Orozco TT, Solano MO, Sandoval GF et al. Inflammatory mediators in patients with atopic dermatitis after treatment with transfer factor. Rev Alerg Mex 2004; 51: 151-4.
12. Pizza G, Chiodo F, Colangeli V, F et al. Preliminary observations using HIV-specific transfer factor in AIDS. Biotherapy 1996; 9: 41-7.
13. Price P, Mcmillan TJ. Use of the tetrazolium assay in measuring the response of human tumor cells to ionizing radiation. Cancer Res 1990; 50: 1392-6.
14. Chen J, Song X, Zhang H, Qu YB, Miao JY. Sophorolipid produced from the new yeast strain Wickerhamiella domercqiae induces apoptosis in H7402 human liver cancer cells. Appl Microbiol Biotechnol 2006; 72: 52-9.
15. Shirabe K, Takenaka K, Gion T, Shimada M, Fujiwara Y, Sugimachi K. Significance of alpha-fetoprotein levels for detection of early recurrence of hepatocellular carcinoma after hepatic resection. J Clin Oncol 1997; 64: 143-6.
16. Okuda N, Nakao A, Takeda S et al. Clinical significance of alpha-fetoprotein mRNA during perioperative period in HCC. Hepatogastroenterology 1999; 46: 381-6.
17. Aoyagi Y, Mita Y, Suda T et al. The fucosylation index of serum α-fetoprotein as useful prognostic factor in patients with hepatocellular carcinoma in special reference to chronological changes. Hepatol Res 2002; 23: 287-95.
18. Franco MM, Mendoza EG, Miranda DH et al. In vitro effects of bovine dialyzable leukocyte extract (bDLE) in cancer cells. Cytotherapy 2006; 8: 408-4.
19. Fernandez CO, Dubed M, Ramos Y et al. Non-induced leukocyte extract reduces HIV replication and TNF secretion. Biochem Biophys Res Commun 2004; 325: 1075-81.
20. Antonin V, Michal H, Karel B et al. Positive effects of dialyzable leukocyte extract (DLE) on recovery of mouse haemopoiesis suppressed by ionizing radiation and on proliferation of haemopoietic progenitor cells in vitro. Int J Immunophar 2000; 22: 623-34.
21. Wang X, Yuan JH, Zhang RG et al. Antihepatoma effect of alpha-fetoprotein antisense phosphorothioate oligodeoxyribonucleotides in vitro and in mice. World J Gastroenterol 2001; 7: 345-51.
22. Zhang M, Gong Y, Assy N, Minuk GY. Increased GAB Aergic activity inhibits alpha-fetoprotein mRNA expression and the proliferative activity of the HepG2 human hepatocellular carcinoma cell line. J Hepatol 2000; 32: 85-91.
23. Wang YS, Ma XL, Qi TG et al. Downregulation of alpha-fetoprotein siRNA inhibits proliferation of SMMC-7721 cells. World J Gastroenterol 2005; 11: 6053-5.
24. Wang XW, Xie H. Alpha fetoprotein enhances the proliferation of human hepatoma cells in vitro. Life Sci 1999; 64: 17-23.
25. Green GR, Reed JC. Mitochondria and apoptosis. Apoptosis 1998; 281: 1309-12.
26. Oltvai ZN, Milliman CL, Korsmeyer SJ. Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death. Cell 1993; 74: 609-19.
27. 2+ signaling and apoptosis. J Bioenerg Biomembr 2000; 32: 35-46.
28. Jiang X, Wang X. Cytochrome C-mediated apoptosis. Annu Rev Biochem 2004; 73: 87-106.